Skip to main content

Table 3 Rs3733591 and tophaceous gout in the Māori, EP, WP and NZ Caucasian casesa

From: The SLC2A9 nonsynonymous Arg265His variant and gout: evidence for a population-specific effect on severity

 

Tophaceous cases, n(OR)

Nontophaceous cases, n(OR)

    

Sample set

CC

CT

TT

C-allele frequency

CC

CT

TT

C-allele frequency

Genotypic P

Allelic P

P STRAT

Allelic OR, C allele (95% CI)

Māori

36 (0.692)

13 (0.250)

3 (0.058)

0.817

37 (0.446)

37 (0.446)

9 (0.108)

0.669

0.02

0.008

0.01

2.21 (1.22 to 4.01)

EP

43 (0.652)

17 (0.258)

6 (0.091)

0.780

48 (0.490)

41 (0.418)

9 (0.092)

0.699

0.09

0.10

0.17

1.53 (0.92 to 2.55)

WP

22 (0.234)

46 (0.489)

26 (0.277)

0.479

16 (0.213)

41 (0.547)

18 (0.240)

0.487

0.76

0.88

0.54

0.97 (0.63 to 1.48)

NZ Caucasian

63 (0.656)

30 (0.313)

3 (0.031)

0.812

158 (0.715)

57 (0.258)

6 (0.027)

0.844

0.58

0.33

-

0.88 (0.51 to 1.24)

  1. aCI, confidence interval; OR, odds ratio; CI, confidence interval; EP, Eastern Polynesian; NZ, New Zealand; WP, Western Polynesian; PSTRAT = STRAT test for association.